DC Circ. Revives Terror-Funding Case Against AstraZeneca
By Khorri Atkinson · January 4, 2022, 5:43 PM EST
The D.C. Circuit on Tuesday revived a lawsuit accusing AstraZeneca, Pfizer and several other pharmaceutical companies of helping to finance terror acts — through lucrative medical goods contracts with Iraq's health...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login